Direct Biologics reveals successful outcomes from EXIT COVID-19 Phase II Clinical Trial
Apr 06, 2022
Austin [Texas], April 6 (ANI/PRNewswire): Direct Biologics, a regenerative biotechnology company with a lifesaving mesenchymal stem cell (MSC) derived extracellular vesicle (EV) platform technology,...